Avantax Advisory Services’s Zai Lab ZLAB Stock Holding History

Avantax Advisory Services’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$275K	Buy	7,878 +1,644	+26%	+$54.1K	﹤0.01%	1984
2025 Q1	$225K	Buy	+6,234	New	+$192K	﹤0.01%	2034

Other funds holding ZLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Avantax Advisory Services's ZLAB Position: Q2 2025 in Review

Avantax Advisory Services increased its Zai Lab (ZLAB) stake by 26% in Q2 2025, buying an estimated $54.1K and bringing the position to 7,878 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Avantax Advisory Services first reported a position in ZLAB in Q1 2025 and has held it in 2 quarters since. 156 funds tracked by Wall St. Rank hold ZLAB as of Q2 2025.

Avantax Advisory Services held 7,878 shares of Zai Lab worth $275K as of Q2 2025.
Avantax Advisory Services bought 1,644 Zai Lab shares in Q2 2025, an estimated $54.1K.
Zai Lab made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1984 holding.
Avantax Advisory Services first reported a position in Zai Lab in Q1 2025 and has held it in 2 quarters since.
156 funds tracked by Wall St. Rank held Zai Lab as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.